Loren Data's SAM Daily™

FBO DAILY ISSUE OF AUGUST 03, 2009 FBO #2809
SOLICITATION NOTICE

66 -- Argos Model 2400 BB-15 CW OPO with B range Module

Notice Date

8/1/2009
 

Notice Type

Presolicitation
 

NAICS

334516 — Analytical Laboratory Instrument Manufacturing
 

Contracting Office

Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
 

ZIP Code

20857-0001
 

Solicitation Number

FDA-SOL-09-1059300
 

Archive Date

8/25/2009
 

Point of Contact

Jeankite L Joseph, Phone: 301-827-5095, Christopher E. Cunningham, Phone: 301-827-7185
 

E-Mail Address

jeankite.joseph@fda.hhs.gov, christopher.cunningham@fda.hhs.gov
(jeankite.joseph@fda.hhs.gov, christopher.cunningham@fda.hhs.gov)
 

Small Business Set-Aside

Total Small Business
 

Description

NOTICE This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. The solicitation, FDA-SOL-09-1059300, is issued as a Request for Quotes (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 05-35. The acquisition is set-aside for Small Business. The associated NAICS code is 334516 and small business size standard is $ 500.0 Millions. The Food and Drug Administration (FDA) seeks competition for the following equipment: -ARGOS MODEL 2400 BB-15 CW OPO with B range Module NOTE: MUST BE EXACT MATCHED Evaluation: Specifications • The IR Widely Tunable High-Power Laser System must possess a broad tuning spectral range in the near/mid-IR: 1.6-1.85 μm and 2.5-3.2 μm • The IR Widely Tunable High-Power Laser System must possess a high average output power: >1 W • The IR Widely Tunable High-Power Laser System must possess a narrow spectral linewidth: < 6 nm • The IR Widely Tunable High-Power Laser System must possess a laser beam quality of M2< 1.1 • The IR Widely Tunable High-Power Laser System must have a Power stability: < 5% rms • The IR Widely Tunable High-Power Laser System must be a compact, all-solid-state, IR tunable laser system Evaluation Criteria • 20 Points - The IR Widely Tunable High-Power Laser System must possess a broad tuning spectral range in the near/mid-IR: 1.6-1.85 μm and 2.5-3.2 μm • 30 Points - The IR Widely Tunable High-Power Laser System must possess a high average output power: >1 W • 10 Points - The IR Widely Tunable High-Power Laser System must possess a narrow spectral linewidth: < 6 nm • 10 Points - The IR Widely Tunable High-Power Laser System must possess a laser beam quality of M2< 1.1 • 20 Points - The IR Widely Tunable High-Power Laser System must have a Power stability: < 5% rms • 10 Points - The IR Widely Tunable High-Power Laser System must be a compact, all-solid-state, IR tunable laser system Price: FDA will evaluate the offeror's submission/proposal on their ability to provide support at a reasonable and realistic price (to include any discounts offered). OFFEROR MUST COMPLETE AND SUBMIT WITH ITS QUOTE, FAR 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS – COMMERCIAL ITEMS (JUL 2009), WHICH ARE AVAILABLE ELECTRONICALLY AT: http://www.arnet.gov/far/current/html/52_212_213.html. The clause at FAR 52.212-4 (Mar. 2009), Contract Terms and Conditions – Commercial Items and FAR 52.212-5 (Jun. 2009), Contract Terms and Conditions required to Implement Statutes or Executive Orders – Commercial Items, applies to this acquisition. The additional FAR clauses cited in the clause are applicable to the acquisition: (1) 52.203-6 Restrictions on Subcontractor Sales to the Government, with Alternate I (Sep. 2006), (2) 52.219-8, Utilization of Small Business Concerns (May 2004), (3) 52.219-14, Limitations on Subcontracting (DEC 1996), (4) 52.222-21 Prohibition of Segregated Facilities (FEB 1999), (5) 52.222-26 Equal Opportunity (MAR 2007), (6) 52.222-35 Equal Opportunity for Special Disabled Veterans, Veterans of the Vietnam Era, and Other Eligible Veterans (Sept 2006), (7) 52.222-36 Affirmative Action for Workers and Disabilities (JUN 1998), (8) 52.222-37 Employment Reports on Special Disabled Veterans, Veterans on the Vietnam Era, and Other Eligible Veterans (Sept 2006) (9) 52.222-19 Child Labor-Cooperation with Authorities and Remedies (Feb 2008) (10) 52.225-13 Restrictions on Certain Foreign Purchases (June 2008) (11) 52.232-33 Payment by Electronic Funds Transfer (Oct 2003). (12) 52.204-7 Central Contractor Registration (Apr 2008). (13) 52.217-7 Option for Increased Quantity—Separately Priced Line Item (Mar 1989) (14) 52.217-8 Option to Extend Services (Nov 1999). (15) 52.217-9 Option to Extend the Term of the Contract (Mar 2000).. Award will be made to the offeror providing the lowest price to the Government. The Contract Specialist must receive any questions no later than August 04, 2009. Offerors cost proposal shall be received on or before 2:00 P.M. local time, August 07, 2009 at Food and Drug Administration 5630 Fishers Lane Rockville, MD 20857. For information regarding this solicitation, please contact Jeankite Joseph, at 301-827-5095, Fax 301-827-7106, or email: jeankite.joseph@fda.hhhs.gov
 

Web Link

FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-SOL-09-1059300/listing.html)
 

Place of Performance

Address: 10903 New Hampshire Avenue, Buiding WO62, Silver Spring, Maryland, 20993, United States

Zip Code: 20993
 

Record

SN01896390-W 20090803/090802041148-9f0f1c33c3f2d321dfd410fcb2cee1ae (fbodaily.com)
 

Source

FedBizOpps Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |